Backers of California’s stem cell agency are seeking to qualify a $5.5 billion bond measure for the statewide ballot in November 2020.
- In 2004, California voters approved $3 billion in bonds to fund such research
- Payments on new bonds to be postponed for the first five years to protect the general fund, according to language submitted to the state attorney general
- Debt costs would be spread out over 40 years so that “repayment is aligned with the period of time over which California patients are expected to benefit from institute-funded research”
To contact the reporter on this story:
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.